Latest Stock Split Details
Key information about TransCode Therapeutics, Inc.'s most recent stock split
Split Date: 2025-05-15
Split Ratio: 1:28
Price Before Split: $0.27
Price After Split: $0.01
Developer API
Get RNAZ split history as JSON
Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.
GETapi.roic.ai/v2/stock-splits/RNAZ
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 28.00 times fewer shares (a 1:28 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of TransCode Therapeutics, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2025-05-15 | 1:28 | Yes | $0.27 | $0.01 |
| 2024-12-04 | 1:33 | Yes | $0.21 | $0.01 |
| 2024-01-16 | 1:40 | Yes | $0.07 | $0.00 |
| 2023-05-23 | 1:20 | Yes | $0.22 | $0.01 |
About TransCode Therapeutics, Inc.
Company overview and industry information
TransCode Therapeutics, Inc. (RNAZ) operates in the Biotechnology industry. The recent 1-for-28 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to TransCode Therapeutics, Inc. Summary